Prevention of Infection in Indian Neonates - Phase II Probiotics Study

Inclusion Criteria: * Infants ≥ 35 weeks and ≥1800g born in the hospital * Infants \> 12 hours and \< 72 hours of age at enrollment * Infants likely to be hospitalized for 5-7 days without antibiotic treatment * Informed consent by one parent or guardian * Infants begun breastfeeding Exclusion Criteria: * Antibiotic therapy prior to enrollment * Evidence or suspicion of clinical sepsis before randomization * Inability (as determined by the physician) to tolerate oral feeding of study supplement * Presence of major congenital anomalies * Infant's home is \>30km away from hospital A major congenital anomaly is defined as any malformation that is felt to be life-threatening or that requires surgical intervention. If the medical officer is uncertain whether an anomaly is life-threatening, he/she should not enroll the infant.